SCHEMBL4780198

SCHEMBL4780198

COc1ccc(C)c(-c2ccccn2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
RUNX1 Q01196 1/20 0.50
CCR1 P32246 1/20 0.47
CCR5 P51681 1/20 0.47
CCR8 P51685 1/20 0.47
NPY5R Q15761 1/20 0.47
FFAR1 O14842 2/20 0.47
SYK P43405 2/20 0.46
KDR P35968 1/20 0.45
PKM P14618 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 1/20 0.45
GRM5 P41594 1/20 0.45
HSP90AA1 P07900 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
TGFBR1 P36897 2/20 0.44
LRRK2 Q5S007 1/20 0.44
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23571783 0.88 HSD17B10 (0.47) NPC1RAB9ACCR1CCR5CCR8
SCHEMBL4726334 0.87 NPC1 (0.50) NPC1RAB9ARUNX1CCR1CCR5
SCHEMBL16801196 0.84 TGFBR1 (0.44) NPC1RAB9ARUNX1FFAR1KDR
SCHEMBL15906385 0.84 MAPK1 (0.53) NPC1RAB9AFFAR1PKMSMN1; SMN2
SCHEMBL29496943 0.83 SYK (0.56) NPC1RAB9ARUNX1CCR1CCR5
SCHEMBL28838408 0.82 RAB9A (0.49) NPC1RAB9ARUNX1CCR1CCR5
SCHEMBL29978781 0.81 RAB9A (0.48) NPC1RAB9ARUNX1CCR1CCR5
SCHEMBL12946320 0.81 SYK (0.50) NPC1RAB9ARUNX1CCR1CCR5
SCHEMBL5326831 0.80 IDH1 (0.58) NPC1RAB9ARUNX1CCR1CCR5
SCHEMBL5379182 0.80 SYK (0.56) NPC1RAB9ARUNX1CCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3110818-B1 9H-PYRIMIDO[4,5-B]INDOLES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS UNIV MICHIGAN REGENTS (US) 2019-10-23 EP disclosed
US-20170210761-A1 9H-PYRIMIDO [4,5-B]INDOLES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-07-27 US disclosed
US-9580430-B2 9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-02-28 US disclosed
US-20150246923-A1 9H-PYRIMIDO[4,5-B]INDOLES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2015-09-03 US disclosed
WO-2008024953-A2 TRANSITION METAL-CATALYZED ALKYLATION OF C-H BONDS WITH ORGANOBORON REAGENTS BRANDEIS UNIVERSITY (US) 2008-02-28 WO disclosed
WO-2008024953-A2 TRANSITION METAL-CATALYZED ALKYLATION OF C-H BONDS WITH ORGANOBORON REAGENTS BRANDEIS UNIVERSITY (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170210761-A1 9H-PYRIMIDO [4,5-B]INDOLES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS BRD4, BRD3, BRD1 NPC1 3924/4885RAB9A 895/4885RUNX1 394/4885
US-20150246923-A1 9H-PYRIMIDO[4,5-B]INDOLES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS BRD4, BRD3, BRD1 NPC1 3924/4885RAB9A 895/4885RUNX1 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.